Published in Front Immunol on March 10, 2017
Editorial: Vaccines, Immunotherapy and New Antifungal Therapy against Fungi: Updates in the New Frontier. Front Microbiol (2017) 0.75
Hidden killers: human fungal infections. Sci Transl Med (2012) 7.10
Immunity to fungal infections. Nat Rev Immunol (2011) 4.33
Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc Natl Acad Sci U S A (1989) 2.73
Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide. Infect Immun (1987) 2.61
Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen. Infect Immun (1986) 2.56
A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med (2005) 2.35
Coccidioidomycosis: host response and vaccine development. Clin Microbiol Rev (2004) 1.82
Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of Paracoccidioides brasiliensis which induces a Th-1 response protective against fungal infection in BALB/c mice. Infect Immun (1998) 1.69
Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J Exp Med (2003) 1.58
Cloning, characterization, and epitope expression of the major diagnostic antigen of Paracoccidioides brasiliensis. J Biol Chem (1996) 1.58
Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J Immunol (1999) 1.54
Calnexin induces expansion of antigen-specific CD4(+) T cells that confer immunity to fungal ascomycetes via conserved epitopes. Cell Host Microbe (2015) 1.48
In vivo and in vitro activation of pulmonary macrophages by IFN-gamma for enhanced killing of Paracoccidioides brasiliensis or Blastomyces dermatitidis. J Immunol (1988) 1.32
Paracoccidioidomycosis: eco-epidemiology, taxonomy and clinical and therapeutic issues. Future Microbiol (2013) 1.28
Is the geographical origin of a Paracoccidioides brasiliensis isolate important for antigen production for regional diagnosis of paracoccidioidomycosis? Mycoses (2009) 1.22
Polymorphism in the gene coding for the immunodominant antigen gp43 from the pathogenic fungus Paracoccidioides brasiliensis. J Clin Microbiol (2000) 1.22
The 43-kDa glycoprotein from the human pathogen Paracoccidioides brasiliensis and its deglycosylated form: excretion and susceptibility to proteolysis. Arch Biochem Biophys (1991) 1.19
DNA-based vaccination against murine paracoccidioidomycosis using the gp43 gene from paracoccidioides brasiliensis. Vaccine (2000) 1.18
A novel Th cell epitope of Candida albicans mediates protection from fungal infection. J Immunol (2012) 1.17
Curcumin as a promising antifungal of clinical interest. J Antimicrob Chemother (2008) 1.17
Melanin in the dimorphic fungal pathogen Paracoccidioides brasiliensis: effects on phagocytosis, intracellular resistance and drug susceptibility. Microbes Infect (2005) 1.15
A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery. J Immunol (2002) 1.13
Mechanisms of Candida biofilm drug resistance. Future Microbiol (2013) 1.13
Paracoccidioides brasiliensis-gp43 used as paracoccidioidin. J Med Vet Mycol (1996) 1.11
The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected BALB/c mice challenged intratracheally with the fungus. Infect Immun (2008) 1.10
Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders. AIDS (2012) 1.10
An overview of the immunopathology of human paracoccidioidomycosis. Mycopathologia (2008) 1.09
Beta-glucan-CRM197 conjugates as candidates antifungal vaccines. Vaccine (2010) 1.09
A protective domain of heat-shock protein 60 from Histoplasma capsulatum. J Infect Dis (1996) 1.08
Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host Microbe (2012) 1.07
Therapeutic DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis. PLoS Negl Trop Dis (2012) 1.05
Prophylactic and therapeutic vaccination using dendritic cells primed with peptide 10 derived from the 43-kilodalton glycoprotein of Paracoccidioides brasiliensis. Clin Vaccine Immunol (2011) 1.04
The protective immune response to heat shock protein 60 of Histoplasma capsulatum is mediated by a subset of V beta 8.1/8.2+ T cells. J Immunol (2002) 1.02
Developing a vaccine against aspergillosis. Med Mycol (2010) 0.99
Development of vaccines for Candida albicans: fighting a skilled transformer. Nat Rev Microbiol (2013) 0.98
Nature of the reactive epitopes in Paracoccidioides brasiliensis polysaccharide antigen. J Med Vet Mycol (1994) 0.98
Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis. Infect Immun (2012) 0.97
CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine. Infect Immun (2011) 0.96
The in vitro susceptibility of Scedosporium prolificans to ajoene, allitridium and a raw extract of garlic (Allium sativum). J Antimicrob Chemother (2003) 0.94
Attempts at a peptide vaccine against paracoccidioidomycosis, adjuvant to chemotherapy. Mycopathologia (2008) 0.91
Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis. Infect Immun (2007) 0.91
An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection. Vaccine (2012) 0.91
The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide. Front Microbiol (2012) 0.89
Protective Effector Cells of the Recombinant Asp f3 Anti-Aspergillosis Vaccine. Front Microbiol (2012) 0.87
Efflux pump proteins in antifungal resistance. Front Pharmacol (2014) 0.87
Opportunistic fungi and fungal infections: the challenge of a single, general antifungal vaccine. Expert Rev Vaccines (2006) 0.86
Synthetic peptide vaccines: unexpected fulfillment of discarded hope? Biologicals (2002) 0.86
Immunization with P10 peptide increases specific immunity and protects immunosuppressed BALB/c mice infected with virulent yeasts of Paracoccidioides brasiliensis. Mycopathologia (2014) 0.86
Curcumin as a promising anticandidal of clinical interest. Can J Microbiol (2011) 0.85
Ajoene in the topical short-term treatment of tinea cruris and tinea corporis in humans. Randomized comparative study with terbinafine. Arzneimittelforschung (1999) 0.83
Importance of adhesins in virulence of Paracoccidioides spp. Front Microbiol (2015) 0.83
Vaccine immunity against fungal infections. Curr Opin Immunol (2014) 0.82
Cryptococcal therapies and drug targets: the old, the new and the promising. Cell Microbiol (2016) 0.82
Vaccine progress. Med Mycol (2009) 0.82
Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c mice. Hum Vaccin Immunother (2014) 0.82
Aspergillosis and stem cell transplantation: An overview of experimental pathogenesis studies. Virulence (2016) 0.82
Novel strategies to enhance vaccine immunity against coccidioidomycosis. PLoS Pathog (2013) 0.81
Antifungal therapeutics for dimorphic fungal pathogens. Virulence (2016) 0.81
Experimental paracoccidioidomycosis: alternative therapy with ajoene, compound from Allium sativum, associated with sulfamethoxazole/trimethoprim. Med Mycol (2008) 0.81
TLR-4 cooperates with Dectin-1 and mannose receptor to expand Th17 and Tc17 cells induced by Paracoccidioides brasiliensis stimulated dendritic cells. Front Microbiol (2015) 0.80
Synthesis and immunological studies of linear oligosaccharides of β-glucan as antigens for antifungal vaccine development. Bioconjug Chem (2015) 0.80
Anti-Immune Strategies of Pathogenic Fungi. Front Cell Infect Microbiol (2016) 0.79
Exploring the molecular basis of antifungal synergies using genome-wide approaches. Front Microbiol (2012) 0.78
Protective role of Th17 cells in pulmonary infection. Vaccine (2016) 0.78
Histoplasma capsulatum, lung infection and immunity. Future Microbiol (2015) 0.77
Anti-metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10. Immunol Cell Biol (2014) 0.77
HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos Santos. World J Biol Chem (2010) 0.77
A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo. Sci Rep (2015) 0.77
Vaccines against Coccidioides. Korean J Intern Med (2013) 0.76
A subtraction tolerization method of immunization allowed for Wilms' tumor protein-1 (WT1) identification in melanoma and discovery of an antitumor peptide sequence. J Immunol Methods (2014) 0.76
Paracoccidioides brasiliensis AND Paracoccidioides lutzii, A SECRET LOVE AFFAIR. Rev Inst Med Trop Sao Paulo (2015) 0.76
Immunotherapy of Fungal Infections. Immunol Invest (2015) 0.76
Potential Antifungal Targets against a Candida Biofilm Based on an Enzyme in the Arachidonic Acid Cascade-A Review. Front Microbiol (2016) 0.76